Jamesskafte9113

OBJECTIVE Lower BP during romantic partner interactions may underlie the association between romantic relationships and better long-term cardiovascular health.This secondary analysis examined the effect of momentary ABP response to partner interactions on between-person changes in LVMI and mean systolic and diastolic BP over time. METHODS Participants were 538 married, working adults (M = 46.9, SD = 8.8 years old; 56.7% female) with a screening BP of less then 160/105 mmHg. Participants completed questionnaires, 24-hour ABP monitoring, and an echocardiogram at waves 1 and 2 (M = 6.2, SD = 1.0 years later). Associations between ABP response to partner (vs. non-partner) interactions and cardiovascular outcomes were examined using multilevel structural equation models. RESULTS Participants with lower diastolic BP during partner interactions at wave 1 had a lesser increase in systolic BP at wave 2, B = 1.68, se = 0.61, p = .006 (9.84 mmHg differential change in systolic BP for participants at +1/-1 SD diastolic ABP response to partner interactions). Participants with lower diastolic ABP during partner-specific interactions at wave 1 also had a lesser increase in diastolic BP, B = 0.83, se = 0.42, p = .045 (4.89 mmHg differential change in diastolic BP at +1/-1 SD). Systolic ABP response to partner-specific interactions did not predict changes in cardiovascular outcomes; diastolic ABP response did not predict changes in LVMI. CONCLUSIONS Momentary diastolic ABP response to partner-specific interactions may function as a mechanism underlying the cardioprotective effect of romantic relationships on long-term BP outcomes.Midlife obesity has been associated with poor cognitive functioning in older age, but the bidirectional pathways linking the brain and excessive adipose tissue require further research. In this issue of Psychosomatic Medicine, two investigations address the brain responses to food-related cues and psychological stressors relevant to obesity. Moazzami and colleagues document the relationship between abdominal obesity and brain responses to stress among patients with coronary artery disease and find that stress-related brain activity plays a potentially important role in the link between psychological distress, food cravings and eating patterns relevant to obesity. Donofry and colleagues compare food cue-evoked functional connectivity in adults with obesity and report that brain areas involved in impaired self-regulation and reward processing may increase the risk of obesity by influencing decisions regarding diet and exercise. In this editorial, these findings are discussed in the context of brain-obesity interactions and the need for personalized multidisciplinary interventions for obesity. It is possible that fMRI and other indices of brain functioning will be useful in tailoring interventions that target weight reduction and/or cognitive functioning and monitoring treatment progress.Pocapavir exhibits antiviral activity against both polio and nonpolio enteroviruses. There is limited experience of the use of this investigational drug in young children with enteroviral infection. We describe the successful clearance of prolonged immunodeficiency-associated vaccine-derived type 3 poliovirus infection by pocapavir in an infant with underlying X-linked agammaglobulinemia.BACKGROUND Although necrotizing pneumonia (NN) is one of the most feared complications of community-acquired pneumonia, data in pediatric patients are scarce. The objective of this article is to describe children admitted to pediatric intensive care unit (PICU) because of NN. METHODS Retrospective-prospective observational study in children admitted with NN to PICU (from January 1, 2010, to December 31, 2018). The data collected included information on disease epidemiology, PICU management, respiratory assistance and disease evolution. RESULTS Fifty-one children were included, 42 of 51 had received 7-valent or 13-valent pneumococcal vaccine. Median age was 3.2 years (1.9-4.2), 15 of 51 had signs of sepsis at admission. Forty-nine patients presented pleural effusion with drainage in 46. The most common respiratory support modality was high-flow oxygen nasal cannula (17/51). Computed tomography was the gold standard for diagnosis. Etiological diagnosis was obtained in 34 of 51, and pneumococcus was isolated in 29 of 34. In all of these cases, initial detection was made by capsular antigen in pleural fluid. Children with pneumococcal NN had fewer days of evolution prior to PICU admission (P = 0.041). Cefotaxime with clindamycin was used in 49 of 51. Surgery was necessary in 3 of 51 patients. After PICU discharge, only 5 of 51 were readmitted. Apcin There were deaths. CONCLUSIONS In our study, the NN was mainly observed in children around 3 years old. The main causal agent was pneumococcus. The evolution towards NN appeared to be faster than in case of other etiologies. Surgery management was unusual. All children required prolonged admissions but had a full clinical recovery.BACKGROUND Clinical trials for antibiotics designed to treat hospital-acquired and ventilator-associated bacterial pneumonias (HABP/VABP) are hampered by making these diagnoses in a way that is acceptable to the United States Food and Drug Administration and consistent with standards of care. We examined laboratory and clinical features that might improve pediatric HABP/VABP trial efficiency by identifying risk factors predisposing children to HABP/VABP and describing the epidemiology of pediatric HABP/VABP. METHODS We prospectively reviewed the electronic medical records of patients less then 18 years of age admitted to intensive and intermediate care units (ICUs) if they received qualifying respiratory support or were started on antibiotics for a lower respiratory tract infection or undifferentiated sepsis. Subjects were followed until HABP/VABP was diagnosed or they were discharged from the ICU. Clinical, laboratory and imaging data were abstracted using structured chart review. We calculated HABP/VABP incidence and used a stepwise backward selection multivariable model to identify risk factors associated with development of HABP/VABP. RESULTS A total of 862 neonates, infants and children were evaluated for development of HABP/VABP; 10% (82/800) of those receiving respiratory support and 12% (103/862) overall developed HABP/VABP. Increasing age, shorter height/length, longer ICU length of stay, aspiration risk, blood product transfusion in the prior 7 days and frequent suctioning were associated with increased odds of HABP/VABP. The use of noninvasive ventilation and gastric acid suppression were both associated with decreased odds of HABP/VABP. CONCLUSIONS Food and Drug Administration-defined HABP/VABP occurred in 10%-12% of pediatric patients admitted to ICUs. Risk factors vary by age group.